Huimeng Sun

A molecular dynamics investigation on the crizotinib resistance mechanism of C1156Y mutation in ALK.

Huimeng Sun, Feng-Qin Ji, Hui-Yong Sun, 2012, Biochemical and biophysical research communications.

A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma

Z. Zhao, Hong Xu, Huimeng Sun, 2022, Frontiers in Genetics.

The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis

Huimeng Sun, Jinhuan Wang, Lanfang Li, 2022, Expert review of hematology.

Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review

Z. Zhao, Hong-lin Xu, Huimeng Sun, 2023, Frontiers in Immunology.

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma

Hong-lin Xu, Wenqi Wu, Huimeng Sun, 2021, Frontiers in Genetics.

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction

Z. Zhao, Xiang He, Huimeng Sun, 2023, Frontiers in Genetics.

The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia

Huimeng Sun, Yanan Jiang, Yixin Zhai, 2024, Cell death discovery.

Comparison of blinatumomab and CAR T-cell therapy in relapsed/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis

Huimeng Sun, Jinhuan Wang, Yanan Jiang, 2023, Expert review of hematology.